10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 250 filers reported holding 10X GENOMICS INC in Q2 2022. The put-call ratio across all filers is 0.59 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $5,028 | -97.7% | 138 | -98.2% | 0.00% | -100.0% |
| Q3 2022 | $215,000 | -37.9% | 7,539 | +2.2% | 0.01% | -58.1% |
| Q2 2022 | $346,000 | -35.8% | 7,378 | +4.2% | 0.03% | +3.3% |
| Q1 2022 | $539,000 | +28.9% | 7,081 | +152.4% | 0.03% | -14.3% |
| Q4 2021 | $418,000 | -29.0% | 2,806 | -13.7% | 0.04% | -25.5% |
| Q1 2021 | $589,000 | +99.7% | 3,253 | +55.9% | 0.05% | +74.1% |
| Q4 2020 | $295,000 | – | 2,086 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |